Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae:: data from the global PROTEKT surveillance programme

被引:98
|
作者
Canton, R
Morosini, M
Enright, MC
Morrissey, I
机构
[1] GR Micro Ltd, London NW1 3ER, England
[2] Univ Bath, Bath BA2 7AY, Avon, England
[3] Hosp Ramon & Cajal, E-28034 Madrid, Spain
关键词
multilocus sequence typing; Spain(23F)-1; topoisomerase mutations; fluoroquinolone resistance;
D O I
10.1093/jac/dkg465
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To analyse the mutations and epidemiology associated with fluoroquinolone-resistant pneumococci collected as part of the PROTEKT global surveillance programme during 1999-2000. Methods: Sixty-nine centres in 25 countries submitted a total of 3362 Streptococcus pneumoniae isolates, for which the MICs of antimicrobial agents were determined using NCCLS methodology. Results: Levofloxacin resistance was low overall (1% worldwide), with higher rates in: Hong Kong (14.3%), South Korea (2.9%), USA (1.8%), Mexico (1.5%), Canada (1.4%) and Japan (1.3%). Levofloxacin resistance was very low or absent in European countries, and absent in Australia. Worldwide, there was a total of 35 levofloxacin-resistant isolates, of which 22 (63%) were resistant and 10 (29%) were intermediate to moxifloxacin. All levofloxacin-resistant isolates were susceptible to telithromycin (less than or equal to0.5 mg/L), linezolid (less than or equal to2 mg/L) and quinupristin/dalfopristin (less than or equal to1 mg/L). One or more mutations in the topoisomerase genes were identified in all levofloxacin-resistant isolates; most of these isolates (33/35) had a mutation in one of the DNA gyrase encoding genes (gyrA, gyrB) and one of the topoisomerase IV encoding genes (parC, parE). Eighteen (51%) isolates carried the same combination of amino acid substitutions: Ser-81-->Phe in GyrA and Ser-79-->Phe in ParC. Isolates displaying a levofloxacin MIC of 2-4 mg/L generally had no mutation or one mutation in either a DNA gyrase or a topoisomerase IV gene, although most mutations were in parC. Conclusions: Most levofloxacin-resistant isolates possess two mutations (one in DNA gyrase and one in topoisomerase IV). Although multilocus sequence typing demonstrated that most of these isolates were unrelated, 12 (34%) were the Spain(23F)-1 clone: 10 from Hong Kong and one each from Saskatchewan, Canada and Sao Paulo, Brazil.
引用
收藏
页码:944 / 952
页数:9
相关论文
共 42 条
  • [21] Antimicrobial Activity of Ceftazidime-Avibactam and Comparators Against Fluoroquinolone-Resistant Klebsiella pneumoniae Collected Globally from Antimicrobial Testing Leadership and Surveillance: 2018-2019
    Kiratisin, Pattarachai
    Arhin, Francis F. F.
    Stone, Gregory
    Utt, Eric
    MICROBIAL DRUG RESISTANCE, 2022, 28 (11) : 1019 - 1027
  • [22] Decline in the prevalence of pandemic clones Spain 23F-1 and Spain9V-3 among US fluoroquinolone-resistant Streptococcus pneumoniae TRUST surveillance isolates since 2001
    Davies, Todd A.
    Yee, Y. Cheung
    Goldschmidt, Raul
    Sahm, Daniel F.
    Evangelista, Alan T.
    POSTGRADUATE MEDICINE, 2008, 120 : 39 - 45
  • [23] Decline in the Prevalence of Pandemic Clones Spain23F-1 and Spain9V-3 Among US Fluoroquinolone-Resistant Streptococcus pneumoniae TRUST Surveillance Isolates Since 2001
    Davies, Todd A.
    Yee, Y. Cheung
    Goldschmidt, Raul
    Sahm, Daniel F.
    Evangelista, Alan T.
    POSTGRADUATE MEDICINE, 2008, : 39 - 45
  • [24] Sporadic occurrences of fluoroquinolone-resistant Streptococcus pneumoniae in the United States:: Longitudinal analysis of institutions from the New England and West South Central regions during the TRUST 4-9 (2000-2005) surveillance studies
    Davies, Todd A.
    Yee, Y. Cheung
    Amsler, Karen
    Goldschmidt, Raul
    Sahm, Daniel F.
    Evangelista, Alan T.
    POSTGRADUATE MEDICINE, 2008, 120 : 25 - 31
  • [25] Molecular Epidemiology and Genetic Diversity of Fluoroquinolone-Resistant Escherichia coli Isolates from Patients with Community-Onset Infections in 30 Chinese County Hospitals
    Zhao, Lina
    Zhang, Jing
    Zheng, Beiwen
    Wei, Zeqing
    Shen, Ping
    Li, Sujuan
    Li, Lanjuan
    Xiao, Yonghong
    JOURNAL OF CLINICAL MICROBIOLOGY, 2015, 53 (03) : 766 - 770
  • [26] Sporadic Occurrences of Fluoroquinolone-Resistant Streptococcus pneumoniae in the United States: Longitudinal Analysis of Institutions from the New England and West South Central Regions During the TRUST 4-9 (2000-2005) Surveillance Studies
    Davies, Todd A.
    Yee, Y. Cheung
    Amsler, Karen
    Goldschmidt, Raul
    Sahm, Daniel F.
    Evangelista, Alan T.
    POSTGRADUATE MEDICINE, 2008, : 25 - 31
  • [27] Global trends in non-susceptibility rates of Streptococcus pneumoniae isolates to ceftriaxone: Data from the antimicrobial testing leadership and surveillance (ATLAS) programme, 2016-21
    Wang, Jiun-Ling
    Lai, Chih-Cheng
    Ko, Wen-Chien
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (02)
  • [28] Molecular epidemiology of penicillin-susceptible non-β-lactam-resistant Streptococcus pneumoniae isolates from Greek children
    Bogaert, D
    Hermans, PWM
    Grivea, IN
    Katopodis, GS
    Mitchell, TJ
    Sluijter, M
    de Groot, R
    Beratis, NG
    Syrogiannopoulos, GA
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) : 5633 - 5639
  • [29] Molecular epidemiology of selected multidrug-resistant bacteria: A global report from the SENTRY Antimicrobial Surveillance Program
    Deshpande, LM
    Fritsche, TR
    Jones, RN
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 49 (04) : 231 - 236
  • [30] Molecular and epidemiological surveillance of polymyxin-resistant Klebsiella pneumoniae strains isolated from Brazil with multiple mgrB gene mutations
    da Silva, Kesia Esther
    To Nguyen Thi Nguyen
    Boinett, Christine J.
    Baker, Stephen
    Simionatto, Simone
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2020, 310 (07)